Fig. 4

Overall survival for patients with NSQ/other histology receiving first-line platinum-based therapy in the pre-ICI and post-ICI periods. Includes only those patients receiving a first-line platinum-based chemotherapy regimen alone (i.e., no ICI therapy in first-line setting). Index date represents the start of first-line therapy. CI Confidence interval, ICI Immune checkpoint inhibitor, NSQ Non-squamous cell, OS Overall survival